BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28103926)

  • 1. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
    Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T
    Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease.
    Ihn H; Asano Y; Kubo M; Yamane K; Jinnin M; Yazawa N; Fujimoto M; Tamaki K
    Rheumatology (Oxford); 2002 Nov; 41(11):1268-72. PubMed ID: 12421999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial lung disease in polymyositis and dermatomyositis.
    Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
    Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].
    Wang PZ; Guan JL; Han XH
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):417-20. PubMed ID: 19031800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
    Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
    J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial lung disease in polymyositis and dermatomyositis.
    Chen IJ; Jan Wu YJ; Lin CW; Fan KW; Luo SF; Ho HH; Liou LB; Tsai WP; Chen JY; Yang CH; Kuo CF; Yu KH
    Clin Rheumatol; 2009 Jun; 28(6):639-46. PubMed ID: 19247576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.
    Kang EH; Lee EB; Shin KC; Im CH; Chung DH; Han SK; Song YW
    Rheumatology (Oxford); 2005 Oct; 44(10):1282-6. PubMed ID: 15972351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
    Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F
    Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Risk Factors of Polymyositis and Dermatomyositis Combined with Interstitial Lung Disease in Patients Residing in the Northeast Sichuan Province of China.
    Li T; Tang ZY; Zhang QB; Xiao FN; Jian GL; Xie Y; Guo JW; Qing YF
    Curr Rheumatol Rev; 2023; 19(4):455-462. PubMed ID: 37005523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung Disease.
    Fukada A; Fujisawa T; Hozumi H; Koda K; Akamatsu T; Oyama Y; Satake Y; Niwa M; Kaida Y; Matsuda H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Hashimoto D; Yoshida A; Gono T; Kuwana M; Yamano Y; Kondoh Y; Yamashita K; Maekawa M; Mori K; Inoue Y; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Inui N; Suda T
    Arthritis Rheumatol; 2024 May; 76(5):796-805. PubMed ID: 38146102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia.
    Kourakata H; Takada T; Suzuki E; Enomoto K; Saito I; Taguchi Y; Tsukada H; Nakano M; Arakawa M
    Respirology; 1999 Sep; 4(3):223-8. PubMed ID: 10489663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels.
    Davis BH; Zarev PV
    Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Outcome in patients with interstitial lung disease and polymyositis-dermatomyositis--a subgroup with poor prognosis].
    Takizawa H; Suzuki N; Yanagawa T; Okazaki H; Satoh M; Akiyama N; Kohyama T; Kawasaki S; Ito K; Oka T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Oct; 34(10):1093-7. PubMed ID: 8953902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
    Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL
    Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum KL-6 in adult patients with polymyositis and dermatomyositis.
    Kubo M; Ihn H; Yamane K; Kikuchi K; Yazawa N; Soma Y; Tamaki K
    Rheumatology (Oxford); 2000 Jun; 39(6):632-6. PubMed ID: 10888708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory biomarkers in polymyositis/dermatomyositis patients with interstitial lung disease: a retrospective study.
    Zhao J; Guo XJ; Shi L
    Curr Med Res Opin; 2024 Jan; 40(1):113-122. PubMed ID: 37938089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.
    Moreno JA; Muñoz-García B; Martín-Ventura JL; Madrigal-Matute J; Orbe J; Páramo JA; Ortega L; Egido J; Blanco-Colio LM
    Atherosclerosis; 2009 Nov; 207(1):103-10. PubMed ID: 19473660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma.
    Jensen TO; Schmidt H; Møller HJ; Høyer M; Maniecki MB; Sjoegren P; Christensen IJ; Steiniche T
    J Clin Oncol; 2009 Jul; 27(20):3330-7. PubMed ID: 19528371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163.
    Møller HJ; Moestrup SK; Weis N; Wejse C; Nielsen H; Pedersen SS; Attermann J; Nexø E; Kronborg G
    Crit Care Med; 2006 Oct; 34(10):2561-6. PubMed ID: 16915112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology.
    Fathi M; Vikgren J; Boijsen M; Tylen U; Jorfeldt L; Tornling G; Lundberg IE
    Arthritis Rheum; 2008 May; 59(5):677-85. PubMed ID: 18438901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.